Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Boerwinkle

Showing results (251-260 of 1,213) with videos related to

Pageof 122
Sort By:
Hypertension (Dallas, Tex. : 1979)|February 9, 2005
Genomic susceptibility loci for brain atrophy in hypertensive sibships from the GENOA studyStephen T Turner, Myriam Fornage, Clifford R Jack, et al.
Hypertension (Dallas, Tex. : 1979)|March 7, 2007
Genetic variations associated with echocardiographic left ventricular traits in hypertensive blacksKristin J Meyers, Thomas H Mosley, Ervin Fox, et al.
Pharmacogenetics and Genomics|April 9, 2009
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT studyAmy I Lynch, Eric Boerwinkle, Barry R Davis, et al.
Frontiers in Public Health|April 11, 2024
Social determinants of health predict readmission following COVID-19 hospitalization: a health information exchange-based retrospective cohort studyMicaela N Sandoval, Jennifer L Mikhail, Melyssa K Fink, et al.
Pharmacogenetics and Genomics|March 6, 2012
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT studyAmy I Lynch, John H Eckfeldt, Barry R Davis, et al.
American Journal of Hypertension|August 20, 2005
Demographic, environmental, and genetic predictors of metabolic side effects of hydrochlorothiazide treatment in hypertensive subjectsAnke-Hilse Maitland-van der Zee, Stephen T Turner, Gary L Schwartz, et al.
American Journal of Epidemiology|June 22, 2013
Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC StudyYan Zheng, Bing Yu, Danny Alexander, et al.
Stroke|June 3, 2006
Novel genomic loci influencing plasma homocysteine levelsIftikhar J Kullo, Keyue Ding, Eric Boerwinkle, et al.
Human Genetics|October 7, 2006
Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injuryMyriam Fornage, Thomas H Mosley, Clifford R Jack, et al.
JAMA Network Open|November 23, 2021
Analysis of COVID-19 Infection and Mortality Among Patients With Psychiatric Disorders, 2020Antonio L Teixeira, Trudy Millard Krause, Lopita Ghosh, et al.
Pageof 122

Showing results (251-260 of 1,213) with videos related to

Sort By:
Pageof 122
Hypertension (Dallas, Tex. : 1979)|February 9, 2005
Genomic susceptibility loci for brain atrophy in hypertensive sibships from the GENOA studyStephen T Turner, Myriam Fornage, Clifford R Jack, et al.
Hypertension (Dallas, Tex. : 1979)|March 7, 2007
Genetic variations associated with echocardiographic left ventricular traits in hypertensive blacksKristin J Meyers, Thomas H Mosley, Ervin Fox, et al.
Pharmacogenetics and Genomics|April 9, 2009
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT studyAmy I Lynch, Eric Boerwinkle, Barry R Davis, et al.
Frontiers in Public Health|April 11, 2024
Social determinants of health predict readmission following COVID-19 hospitalization: a health information exchange-based retrospective cohort studyMicaela N Sandoval, Jennifer L Mikhail, Melyssa K Fink, et al.
Pharmacogenetics and Genomics|March 6, 2012
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT studyAmy I Lynch, John H Eckfeldt, Barry R Davis, et al.
American Journal of Hypertension|August 20, 2005
Demographic, environmental, and genetic predictors of metabolic side effects of hydrochlorothiazide treatment in hypertensive subjectsAnke-Hilse Maitland-van der Zee, Stephen T Turner, Gary L Schwartz, et al.
American Journal of Epidemiology|June 22, 2013
Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC StudyYan Zheng, Bing Yu, Danny Alexander, et al.
Stroke|June 3, 2006
Novel genomic loci influencing plasma homocysteine levelsIftikhar J Kullo, Keyue Ding, Eric Boerwinkle, et al.
Human Genetics|October 7, 2006
Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injuryMyriam Fornage, Thomas H Mosley, Clifford R Jack, et al.
JAMA Network Open|November 23, 2021
Analysis of COVID-19 Infection and Mortality Among Patients With Psychiatric Disorders, 2020Antonio L Teixeira, Trudy Millard Krause, Lopita Ghosh, et al.
Pageof 122